Investigator Initiated Studies (IIS) Program supports independent investigators and institutions studying Eisai products and compounds to address medical or scientific questions in neurology and oncology.
Investigator Initiated Studies (IIS) supports scientists and clinical researchers pursuing independent clinical, observational, and outcomes research to explore questions or develop new treatment concepts.
Investigator Initiated Studies (IIS) supports investigators and research sponsors conducting clinical studies to deepen understanding of Genentech medicines, improve patient care, and inspire disease research.
Investigator-Initiated Studies (IIS) Program supports physician and nurse investigators’ original clinical research using Stryker products to prevent injury, reduce infections, and improve care.
Ionis Pharmaceuticals' Investigator‑Initiated Research Program funds independent studies advancing science in cardiovascular, hereditary angioedema, and neurological diseases.
Investigator-Initiated Research (IIR) supports independent investigators with funding, study drug, or data and samples for research addressing unmet patient needs or important scientific questions.